MedTrace Logo

Effect Of Art Therapy Applied to Individuals With Substance Use Subject to Supervised Release

NCT06057961 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-09-28

No results posted yet for this study

Summary

The goal of this clinical trial is to examine the effect of art therapy applied to individuals with substance use who are subject to probation on difficulty in emotion regulation, self-esteem and hopelessness. The main question\[s\] it aims to answer are:

\[Is art therapy effective on the level of emotion regulation difficulties of individuals with substance use who are subject to probation?\] \[Is art therapy effective on the self-esteem level of individuals with substance use who are subject to probation?\]\[Is art therapy effective on the hopelessness level of individuals with substance use who are subject to probation?\] Data will be collected through scale forms and art therapy sessions. Within the scope of the pre-test application, data will be collected from all participants in the sample group using the "Personal Information Form", "Difficulties in Emotion Regulation Scale-Brief Form (DERS-16)", "Coopersmith Self-Esteem Scale", "Beck Hopelessness Scale". Art therapy will be applied face to face to the participants in the intervention group, in groups of 4-12 people, in the group guide room, on a common day and time determined by the group members and the researchers.

Researchers will compare the experimental group and the control group to see whether art therapy applied to individuals with substance use who are subject to probation has an effect on emotion regulation difficulties, self-esteem and hopelessness.

Conditions

  • Substance Use

Interventions

OTHER

Art Therapy

8 meetings in 1 year

Sponsors & Collaborators

  • Mersin University

    lead OTHER

Principal Investigators

  • Seval Cüceler, PhD · Toros University, Faculty of Health Sciences, Department of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06057961 on ClinicalTrials.gov